- Report
- December 2021
Haiti
From €1662EUR$1,850USD£1,419GBP
- Report
- December 2021
Guatemala
From €1662EUR$1,850USD£1,419GBP
- Report
- December 2021
Greece
From €1662EUR$1,850USD£1,419GBP
- Report
- December 2021
Ghana
From €1662EUR$1,850USD£1,419GBP
- Report
- December 2021
Georgia
From €1662EUR$1,850USD£1,419GBP
- Report
- December 2021
Finland
From €1662EUR$1,850USD£1,419GBP
Immunofixation is a type of in vitro diagnostics (IVD) used to identify and quantify monoclonal immunoglobulins and light chains in serum and urine. It is a two-step process that involves the use of antibodies to separate and identify the components of a sample. The first step involves the use of a polyclonal antibody to separate the sample into its component parts. The second step involves the use of a monoclonal antibody to identify the components of the sample. Immunofixation is used to diagnose and monitor a variety of conditions, including multiple myeloma, Waldenström's macroglobulinemia, and amyloidosis.
The Immunofixation market is a rapidly growing segment of the IVD industry. It is driven by the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the need for accurate and timely diagnosis. Companies in the Immunofixation market include Abbott, Bio-Rad Laboratories, Siemens Healthineers, Ortho Clinical Diagnostics, and Thermo Fisher Scientific. Show Less Read more